Document:

exv10w1

 

Exhibit 10.1

KB HOME UNIT PERFORMANCE PROGRAM

PERFORMANCE MEASURE WEIGHTING

     Pursuant to the terms of the KB Home Unit Performance Program (the “Program”), the Management
Development and Compensation Committee, in its sole discretion, designates from time to time the
relative weighting ascribed to each “Performance Measure” for the purpose of determining award
payouts which may be earned under the Program. The Performance Measures under the Program are
return on investment (“ROI”) and earnings per share (“EPS”), each as calculated pursuant to the
terms of the Program. The Management Development and Compensation Committee has determined that
for purposes of determining all award payouts, the relative weighting of each Performance Measure
is as follows:

	 	 	 	 	 	 	 	 	 
	Corporate-based Participants
	 	75% ROI	 	25% EPS
	(those who principally work at corporate headquarters)
	 	 	 	 	 	 	 	 
	 
	Division-based Participants
	 	50% ROI	 	50% EPS
	(those who principally work at a division or subsidiary)
	 	 	 	 	 	 	 	 

34exv10w1

 

Exhibit 10.1

EMPLOYMENT AGREEMENT

     This Employment Agreement (this “Agreement”) is made and entered into on October 6, 2005, by
and between CytRx Corporation, a Delaware corporation (“Employer”), and Mark A. Tepper, an
individual (“Employee”), and shall be deemed effective as of September 17, 2005 (the “Effective
Date”).

     WHEREAS, Employer and Employee previously entered into an Employment Agreement dated September
17, 2003, under which Employee has served as President of CytRx Laboratories, Inc., a subsidiary of
Employer, which agreement expired by its terms as of September 17, 2005.

     WHEREAS, Employer and Employee desire to enter into a new employment agreement under which
Employee shall serve on a full-time basis as Employer’s Senior Vice President-Drug Discovery on the
terms set forth in this Agreement, with the term of this new employment agreement to commence on
the Effective Date.

     NOW, THEREFORE, upon the above premises, and in consideration of the mutual covenants and
agreements hereinafter contained, the parties hereto agree as follows.

     1. Engagement. Effective as of the Effective Date, Employer shall employ Employee,
and Employee shall serve, as Employer’s Senior Vice President-Drug Discovery.

     2. Duties; Place of Employment. Employee shall perform in a professional and
business-like manner, and to the best of his ability, the duties described on Schedule 1 to this
Agreement and such other duties as are assigned to him from time to time by Employer’s Chief
Executive Officer. Employee understands and agrees that his duties, title and authority may be
changed from time to time in the discretion of Employer’s Chief Executive Officer. Employee’s
services hereunder shall be rendered primarily at Employer’s offices in Worcester, Massachusetts,
or its environs, and to a lesser extent, at Employer’s principal executive offices in Los Angeles,
California.

     3. Time and Efforts. Employee shall devote all of his business time, efforts,
attention and energies to Employer’s business and the discharge of his duties hereunder.
Employee’s services shall be exclusive to Employer during the term of this Agreement.
Notwithstanding the foregoing, Employee shall be entitled to serve without compensation on the
board of directors of not more than three profit or non-profit entities which do not compete with
Employer in the field of treatment, prevention or diagnosis of any disease indication for which
Employer or any subsidiary of Employer is seeking to develop or market products (the “Field”),
provided that such service does not entail a substantial time commitment on Employee’s part and
subject to having first obtained the consent of Employer, which consent shall not unreasonably be
withheld.

     4. Term. The term (the “Term”) of Employee’s employment hereunder shall commence on
the Effective Date and shall expire on the first anniversary thereof, unless

 

 

(a) each of Employer and Employee notifies the other at least 30 days prior to the first
anniversary of the date of this Agreement of its or his intention that this Agreement instead
expire on the second anniversary of the date of this Agreement, which shall then be the expiration
date or (b) sooner terminated in accordance with Section 6. Neither party shall have any
obligation to extend or renew this Agreement.

     5. Compensation. As the total consideration for Employee’s services rendered
hereunder, Employer shall pay or provide Employee the following compensation and benefits:

          5.1. Salary. Employer shall pay Employee an annual salary of Two Hundred Fifty
Thousand Dollars ($250,000), payable in 24 equal semi-monthly installments on the 15th
day and the last day of each calendar month during the Term, with the first such installment due on
September 30, 2005.

          5.2. Discretionary Bonus. Employee may be eligible for an annual bonus for his
services during the Term. Employee’s eligibility to receive a bonus, any determination to award
Employee such a bonus and, if awarded, the amount thereof shall be in Employer’s sole discretion.
In determining whether to award a bonus and the amount, if any, of such bonus, Employer may
consider, among other factors, the achievement by Employer and Employee of the corporate objectives
set forth on Schedule 2 to this Agreement.

          5.3. Intentionally Omitted.

          5.4. Expense Reimbursement. Employer shall reimburse Employee for reasonable and
necessary business expenses incurred by Employee (excluding any car allowance or commuting
expenses) in connection with the performance of Employee’s duties in accordance with Employer’s
usual practices and policies in effect from time to time, as approved by Employer’s Chief Executive
Officer.

          5.5. Vacation. Employee shall be entitled to fifteen business days vacation during
the Term, without loss of salary hereunder, plus holidays, sick leave and personal days as
determined in accordance with Employer’s usual practices and policies in effect from time to time
during the Term.

          5.6. Employee Benefits. Employee shall be eligible to participate in any medical
insurance and other employee benefits made available by Employer to all of its employees under its
group plans and employment policies in effect during the Term. Schedule 3 hereto sets forth a
summary of such plans and policies as currently in effect. Employee acknowledges and agrees that,
any such plans or policies now or hereafter in effect may be modified or terminated by Employer at
any time in its discretion.

          5.7. Tax Withholding. Employer shall have the right to deduct from the compensation
and benefits due to Employee hereunder any and all sums required for social security and
withholding taxes and for any other federal, state, or local tax or charge which may be in effect
or hereafter enacted or required as a charge on the compensation or benefits of Employee.

 

 

     6. Expiration and Termination. This Agreement may be terminated as set forth in this
Section 6.

          6.1. Termination by Employer for Cause. Employer may terminate Employee’s employment
hereunder for “Cause” upon notice to Employee. “Cause” for this purpose shall mean any of the
following:

               (a) Employee’s breach of any material term of this Agreement; provided that the first occasion
of any particular breach shall not constitute such Cause unless Employee shall have previously
received written notice from Employer stating the nature of such breach and affording Employee at
least ten days to correct such breach;

               (b) Employee’s conviction of, or plea of guilty or nolo contendere to, any misdemeanor, felony
or other crime of moral turpitude;

               (c) Employee’s act of fraud or dishonesty injurious to Employer or its reputation;

               (d) Employee’s continual failure or refusal to perform his material duties as required under
this Agreement after written notice from Employer stating the nature of such failure or refusal and
affording Employee at least ten days to correct the same;

               (e) Employee’s act or omission that, in the reasonable determination of Employer’s Board of
Directors (or a Committee of the Board), indicates alcohol or drug abuse by Employee; or

               (f) Employee’s act or personal conduct that, in the judgment of Employer’s Board of Directors
(or a Committee of the Board), gives rise to a material risk of liability of Employee or Employer
under federal or applicable state law for discrimination, or sexual or other forms of harassment,
or other similar liabilities to subordinate employees.

     Upon termination of Employee’s employment by Employer for Cause, all compensation and benefits
to Employee hereunder shall cease and Employee shall be entitled only to payment, not later than
three days after the date of termination, of any accrued but unpaid salary and unused vacation as
provided in Sections 5.1 and 5.5 as of the date of such termination.

          6.2. Termination by Employer without Cause. Employer may also terminate Employee’s
employment without Cause upon five days notice to Employee. Upon termination of Employee’s
employment by Employer without Cause, all compensation and benefits to Employee hereunder shall
cease and Employee shall be entitled to (a) payment of (1) any accrued but unpaid salary and unused
vacation as provided in Sections 5.1 and 5.5 as of the date of such termination, which shall be due
and payable upon the effective date of such termination, and (2) an amount, which shall be due and
payable within ten days following the effective date of such termination, equal to the salary that
would otherwise be payable as provided in Section 5.1 for the

 

 

period (the “Severance Period”) commencing on the date of termination of Employee’s employment
and ending on the six-month anniversary of such date, and (b) continued participation, at
Employer’s cost and expense, during the Severance Period in any Employer-sponsored group benefit
plans in which Employee was participating as of the date of termination.

          6.3. Death or Disability. Employee’s employment will terminate automatically in the
event of Employee’s death or upon notice from Employer in event of his permanent disability.
Employee’s “permanent disability” shall have the meaning ascribed to such term in any
policy of disability insurance maintained by Employer (or by Employee, as the case may be) with
respect to Employee or, if no such policy is then in effect, shall mean Employee’s inability to
fully perform his duties hereunder for any period of at least 75 consecutive days or for a total of
90 days, whether or not consecutive. Upon termination of Employee’s employment as aforesaid, all
compensation and benefits to Employee hereunder shall cease and Employer shall pay to the
Employee’s heirs or personal representatives, not later than ten days after the date of
termination, any accrued but unpaid salary and unused vacation as provided in Sections 5.1 and 5.5
as of the date of such termination.

          6.4. Termination by Employee. Employee shall have the right to voluntarily terminate
his employment hereunder at any time upon 30 days’ written notice to Employer. A voluntary
termination by Employee in accordance with this Section 6.4 shall not be deemed a breach of this
Agreement. Upon any voluntary termination of employment by Employee pursuant to this Section 6.4,
Employee shall be entitled only to such payments and benefits as those described in Section 6.1 for
a termination by Employer for Cause.

     7. Inventions. Employee shall promptly disclose to Employer, and hereby assigns and
agrees to assign to Employer (or as otherwise directed by Employer), his full right, title and
interest to all Inventions (as defined below). Employee agrees to cooperate fully with Employer,
its attorneys and agents, in the preparation and filing of all papers and other documents as may be
required to perfect Employer’s rights in and to any of such Inventions, including, but not limited
to, execution of any and all applications for domestic and foreign patents, copyrights or other
proprietary rights and the performance of such other acts (including, among others, the execution
and delivery of instruments of further assurance or confirmation) requested by Employer to assign
the Inventions to Employer and to permit Employer to file, obtain and enforce any patents,
copyrights or other proprietary rights in the Inventions, all at Employer’s expense. Employee
hereby designates Employer as his agent, and grants to Employer a power of attorney with full power
of substitution, which power of attorney shall be deemed coupled with an interest, for the purpose
of effecting any such assignment hereunder from Employee to Employer. “Inventions” shall mean, for
purposes of this Section 7, ideas, discoveries, creations, manuscripts and properties, innovations,
improvements, know-how, inventions, trade secrets, apparatus, developments, techniques, methods,
biological processes, cell lines, laboratory notebooks and formulas (whether or not patentable or
copyrightable or constituting trade secrets) conceived, made or discovered by Employee (whether
alone or with others) during the Term and/or as a result of confidential

 

 

information (as referred to in Section 8 hereof) received from Employer (as defined therein).
Employee agrees to not use or incorporate any third party proprietary information into any
Inventions or to disclose such information to Employer. Upon termination of this Agreement with
Employer, Employee shall provide to Employer in writing a full, signed statement of all Inventions
in which Employee participated prior to termination of this Agreement.

     8. Confidentiality; Non-Compete. While this Agreement is in effect and for a period
of five years thereafter, Employee shall hold and keep secret and confidential all “trade secrets”
(within the meaning of applicable law) and other confidential or proprietary information of
Employer and shall use such information only in the course of performing Employee’s duties
hereunder; provided, however, that with respect to trade secrets, Employee shall hold and keep
secret and confidential such trade secrets for so long as they remain trade secrets under
applicable law. Employee shall maintain in trust all such trade secrets or other confidential or
proprietary information, as Employer’s property, including, but not limited to, all documents
concerning Employer’s business, including Employee’s work papers, telephone directories, customer
information and notes, and any and all copies thereof in Employee’s possession or under Employee’s
control. Upon the expiration or earlier termination of Employee’s employment with Employer, or
upon request by Employer, Employee shall deliver to Employer all such documents belonging to
Employer, including any and all copies in Employee’s possession or under Employee’s control. For
purposes of Sections 7, 8 and 9, the term “Employer” shall include CytRx Corporation and its
affiliates. During the Term and for a one-year period thereafter (unless Employer terminates this
Agreement without Cause), Employee shall not be employed with or serve as a consultant to or be a
5% or greater shareholder of any entity that is competing, directly or indirectly, with Employer in
the Field, and Employee shall not solicit any employee of Employer for employment with any other
entity.

     9. Equitable Remedies; Injunctive Relief. Employee hereby acknowledges and agrees
that monetary damages are inadequate to fully compensate Employer for the damages that would result
from a breach or threatened breach of this Agreement and, accordingly, that Employer shall be
entitled to equitable remedies, including, without limitation, specific performance, temporary
restraining orders, and preliminary injunctions and permanent injunctions, to enforce such Section
without the necessity of proving actual damages in connection therewith. This provision shall not,
however, diminish Employer’s right to claim and recover damages or enforce any other of its legal
or equitable rights or defenses.

     10. Indemnification; Insurance. Employer and Employee acknowledge that, as the Senior
Vice President – Drug Development of the Employer, Employee shall be a corporate officer of
Employer and, as such, Employee shall be entitled to indemnification to the full extent provided by
Employer to its officers, directors and agents under the Employer’s Certificate of Incorporation
and Bylaws as in effect as of the date of this Agreement. Subject to his insurability thereunder,
Employer shall maintain Employee as an additional insured under its current policy of directors and
officers liability insurance

 

 

and shall use commercially reasonable efforts to continue to insure Employee thereunder, or
under any replacement policies in effect from time to time, during the Term.

     11. Severable Provisions. The provisions of this Agreement are severable and if any
one or more provisions is determined to be illegal or otherwise unenforceable, in whole or in part,
the remaining provisions, and any partially unenforceable provisions to the extent enforceable,
shall nevertheless be binding and enforceable.

     12. Successors and Assigns. This Agreement shall inure to the benefit of and shall be
binding upon Employer, its successors and assigns and Employee and his heirs and representatives.
Neither party may assign this Agreement without the prior written consent of the other party.

     13. Entire Agreement. This Agreement contains the entire agreement of the parties
relating to the subject matter hereof, and the parties hereto have made no agreements,
representations or warranties relating to the subject matter of this Agreement that are not set
forth otherwise herein. This Agreement supersedes any and all prior or contemporaneous agreements,
written or oral, between Employee and Employer relating to the subject matter hereof. Any such
prior or contemporaneous agreements are hereby terminated and of no further effect, and Employee,
by the execution hereof, agrees that any compensation provided for under any such agreements is
specifically superseded and replaced by the provisions of this Agreement.

     14. Amendment. No modification of this Agreement shall be valid unless made in
writing, approved by the Compensation Committee and signed by the parties hereto and unless such
writing is made by an executive officer of Employer (other than Employee). The parties hereto
agree that in no event shall an oral modification of this Agreement be enforceable or valid.

     15. Governing Law. This Agreement is and shall be governed and construed in
accordance with the laws of the State of California without giving effect to California’s
choice-of-law rules.

     16. Notice. All notices and other communications under this Agreement shall be in
writing and mailed, telecopied (in case of notice to Employer only) or delivered by hand or by a
nationally recognized courier service guaranteeing overnight delivery to a party at the following
address (or to such other address as such party may have specified by notice given to the other
party pursuant to this provision):

If to Employer:

CytRx Corporation

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

Facsimile: (310) 826-5529

Attention: Chief Executive Officer

 

 

If to Employee:

Mark A. Tepper, Ph.D.

508 Dudley Road

Newton, MA 02459

Facsimile: (617) 244-0518

     17. Intentionally Omitted.

     18. Survival. Sections 7 through 16 shall survive the expiration or termination of
this Agreement.

     19. Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed to be an original and all of which together shall be deemed to be one and the same
agreement.

     20. Attorney’s Fees. In any action or proceeding to construe or enforce any provision
of the New Employment Agreement the prevailing party shall be entitled to recover its or his
reasonable attorneys’ fees and other costs of suit (up to a maximum of $15,000) in addition to any
other recoveries.

     IN WITNESS WHEREOF, this Agreement is executed as of the day and year first above written.

	 	 	 	 	 
	 	“EMPLOYER”
 
CytRx Corporation,
a Delaware corporation

 	 
	 	By:  	/s/ STEVEN A. KRIEGSMAN
 	 
	 	 	Name:  	Steven A. Kriegsman 	 
	 	 	Title:  	President and Chief Executive Officer 	 
	 
	 	“EMPLOYEE”

 	 
	 	/s/ MARK A. TEPPER
 	 
	 	Mark A. Tepper, Ph.D.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}]]